CompletedNot applicableNCT02538211
The Role of the Intestinal Microbiome in Enteric and Systemic Vaccine Immune Responses
Studying Tetanus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Principal Investigator
- Willem J. Wiersinga, MD, PhDAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
- Intervention
- Rotavirus vaccine, Tetanus vaccine and Pneumococcal vaccine(biological)
- Enrollment
- 63 enrolled
- Eligibility
- 18-35 years · MALE
- Timeline
- 2015 – 2017
Study locations (1)
- Academic Medical Center, Amsterdam, North Holland, Netherlands
Collaborators
Centers for Disease Control and Prevention · Wageningen University and Research
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02538211 on ClinicalTrials.govOther trials for Tetanus
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE1NCT07149454Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Recombinant Human Anti-Tetanus Toxin Monoclonal Antibody InjectionLanzhou Institute of Biological Products Co., Ltd
- RECRUITINGNCT07107932A Registry： Siltartoxatug Injection for Tetanus Prophylaxis Following InjuryZhuhai Trinomab Pharmaceutical Co., Ltd.
- RECRUITINGPHASE3NCT06635798A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 InjectionGenrix (Shanghai) Biopharmaceutical Co., Ltd.